(Q39671865)
Statements
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells (English)
Virginia Seiffart
Jessy Presumey
Virginie Escriou
Daniel Scherman
Jochen Zwerina
Gisela Ruiz
Siegfried Weiss
Andrea Hoffmann